October 28th, 2026PAXAFE’s Mark Talens Sees AI Agents Ending the Dashboard EraAt LogiPharma USA 2026, Mark Talens explains how end-to-end visibility lets pharma see its value chain across functions, and where supply chain monitoring is headed next.Read more
November 20th, 2026Executive Conversations: How Patient Advocacy Is Shaping Channel DesignIn Episode 2, Part 4, Cheryl Allen, Nick Calla and Rena Goins discuss how the industry is building channels around complex products.Read more
November 20th, 2026How Specialty Trade Deals Are Shifting Toward PatientsAsembia's Ray Tancredi explains why manufacturer and specialty pharmacy trade talks now center on getting patients on therapy.Read more
November 19th, 2026Executive Conversations: How Should Manufacturers Reevaluate Their Channel Strategy?In Episode 2, Part 3, Cheryl Allen, Nick Calla and Rena Goins discuss where manufacturers should start when evaluating the channel.Read more
November 18th, 2026Executive Conversations: Where Traditional Channel Models Break DownIn Episode 2, Part 2, Cheryl Allen, Nick Calla and Rena Goins discuss where traditional channel models break down as therapies grow more complex.Read more
November 17th, 2026Executive Conversations: Why Channel Design Should Start With the PatientIn Episode 2, Part 1, Cheryl Allen, Nick Calla and Rena Goins discuss whether today's channel models are ready for an increasingly complex pipeline.Read more
November 16th, 2026Executive Conversations: What Sets Strategic Trade Teams Apart?In Episode 1, Part 4, Jon Hamrick, Rena Goins and Bob Cochran explain what separates trade teams seen as strategic partners from those that aren't.Read more
November 16th, 2026Commercial Pharma Has a Data Debt Problem. Why Minimum Payments Won't Fix It.Fragmented data is eroding trust in pharma insights, and AI raises the stakes. A four-step approach can help organizations pay down their “data debt.”Read more